BRKBX
Price
$22.53
Change
+$0.38 (+1.72%)
Updated
Jun 12 closing price
Net Assets
206.5M
VEMAX
Price
$49.47
Change
+$0.46 (+0.94%)
Updated
Jun 12 closing price
Net Assets
162.82B
Interact to see
Advertisement

BRKBX vs VEMAX

Header iconBRKBX vs VEMAX Comparison
Open Charts BRKBX vs VEMAXBanner chart's image
BRKBX vs VEMAX Comparison Chart in %
View a ticker or compare two or three
VS
BRKBX vs. VEMAX commentary
Jun 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRKBX is a Hold and VEMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEMAX has more cash in the bank: 163B vs. BRKBX (207M). VEMAX pays higher dividends than BRKBX: VEMAX (2.39) vs BRKBX (1.06). BRKBX was incepted earlier than VEMAX: BRKBX (11 years) vs VEMAX (20 years). BRKBX (2.32) is less costly to investors than VEMAX (0.13). BRKBX is a more actively managed with annual turnover of: 57.00 vs. VEMAX (6.00). BRKBX has a lower initial minimum investment than VEMAX: BRKBX (1000) vs VEMAX (3000). BRKBX annual gain was more profitable for investors over the last year : 48.32 vs. VEMAX (23.84). BRKBX return over 5 years is better than : 46.23 vs. VEMAX (20.95).
BRKBXVEMAXBRKBX / VEMAX
Total Expense Ratio1.990.131,531%
Annual Report Gross Expense Ratio2.320.131,785%
Fund Existence11 years20 years-
Gain YTD26.43110.894243%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets207M163B0%
Annual Yield % from dividends1.062.3944%
Returns for 1 year48.3223.84203%
Returns for 3 years89.0254.16164%
Returns for 5 years46.2320.95221%
Returns for 10 years143.08110.71129%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RLAY14.810.57
+4.00%
Relay Therapeutics
EXE88.781.70
+1.95%
Expand Energy Corporation
DGICA17.610.14
+0.80%
Donegal Group
NCPL0.80-0.02
-2.89%
NETCAPITAL INC.
MENS1.58-0.12
-7.33%
Jyong Biotech Ltd